Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer

Oncogene

Volumn 17, Issue 23, 1998, Pages 3021-3027

  Tsutsumi, Masakazu ^a   Tsai, Yvonne C ^a   Gonzalgo, Mark L ^a   Nichols, Peter W ^b   Jones, Peter A ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

9p21; Bladder cancer; DNA methylation; p16 p19, deletion; Squamous metaplasia

Indexed keywords

PROTEIN P16;

ARTICLE; BLADDER CANCER; CARCINOGENESIS; CHROMOSOME 9P; CHROMOSOME DELETION; CHROMOSOME MOSAICISM; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; TRANSITIONAL CELL CARCINOMA;

EID: 0032506745     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202228     Document Type: Article

References (38)

1. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova CJ, Isaacs W, Koch W, Schwab D and Sidransky D. (1995). Nat. Genet., 11, 210-212.
2. Clark SJ, Harrison J, Paul CL and Frommer M. (1994). Nuc. Acids Res., 22, 2990-2997.
3. Duro D, Bernard O, Della-Valle V, Berger R and Larsen CJ. (1995). Oncogene, 11, 21-29.
4. El-Masri WS and Fellows G. (1981). Paraplegia, 19, 265-270.
5. Fueyo J, Gomez-Manzano C, Bruner JM, Saito Y, Zhang B, Zhang W, Levin VA, Yung WK and Kyritsis AP. (1996). Oncogene, 13, 1615-1619.
6. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T and Terada M. (1992). Cancer Res., 52, 1393-1398.
7. Ghaleb AH, Pizzolo JG and Melamed MR. (1996). Am. J. Clin. Pathol., 106, 234-241.
8. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, VanTornout JM and Jones PA. (1995a). Cancer Res., 55, 4531-4535.
9. Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CH III, Busch C, Shamaa M, El. Baz M, Nichols PW, Gonzalgo ML, Malmstom P-U and Jones PA. (1995b). J. Natl. Cancer Inst., 87, 1383-1393.
10. Gonzalgo ML, Hayashida T, Pao MM, Bender CM, Tsai YC, Gonzales FA, Nguyen HD, Nguen TT and Jones PA. (1998). Cancer Res., 58, 1245-1252.
11. Gonzalgo ML and Jones PA. (1997). Nuc. Acids. Res., 25, 2529-2531.
12. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ and Baylin SB. (1997). Cancer Res., 57, 837-841.
13. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and Skolnick MH. (1994). Science, 264, 436-440.
14. Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S, Kane JP and Rossier AB. (1977). J. Urol., 118, 967-971.
15. Keen AJ and Knowles MA. (1994). Oncogene, 9, 2083-2088.
16. Linnenbach AJ, Pressler LB, Seng BA, Kimmel BS, Tomaszewski JE and Malkowiez SB. (1993). Hum. Mol. Genet., 2, 1407-1411.
17. Messing EM and Catalona W. (1997). Urothelial tumors of the urinary tract. In: Walsh PJ, Retik AB, Vaughan Jr ED and Wein AJ (eds.), Campbell's urology. 7th edition: W.B. Saunders: Philadelphia, pp. 2343.
18. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D. (1995). Nature Med., 1, 686-692.
19. Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH III, Gonzalez-Zulueta M, Nichols PW, Skinner DG and Jones PA. (1993). Cancer Res., 53, 4066-4070.
20. Navon JD, Soliman H, Khonsari F and Ahlering T. (1997). J. Urol., 157, 2109-2111.
21. Ng MH, Chung YF, Lo KW, Wickham NW, Lee JC and Huang DP. (1997). Blood, 89, 2500-2506.
22. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA. (1994). Nature, 368, 753-756.
23. Orlow I, Lacombe L, Hannon GJ, Serrano M, Pellicer I, Dalbagni G, Reuter VE, Zhang ZF, Beach D and Cordon-Cardo C. (1995). J. Natl. Cancer Inst., 87, 1524-1529.
24. Packenham JP, Taylor JA, Anna CH, White CM and Devereux TR. (1995). Mol. Carcinogenesis, 14, 147-151.
25. Quelle DE, Zindy F, Ashman RA and Sherr CJ. (1995). Cell, 83, 993-1000
26. Reed AL, Califano J. Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D. (1996). Cancer Res., 56, 3630-3633.
27. Rosin MP, Cairns P, Epstein JI, Schoenberg MP and Sidransky D. (1995). Cancer Res., 55, 5213-5216.
28. Ruppert JM, Tokino K and Sidransky D. (1993). Cancer Res., 53, 5093-5095.
29. Sakamoto N, Tsuneyoshi M and Enjoji M. (1992). Histopathology, 21, 135-141.
30. Serrano M, Hannon G and Beach D. (1993). Nature, 366, 704-707.
31. Singer-Sam J, Lebon JM, Tanguay RL and Riggs AD. (1990). Nuc. Acids Res., 18, 687.
32. Simoneau AR, Spruck CH III, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T and Jones PA. (1996). Cancer Res., 56, 5039-5043.
33. Spruck CH III, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin MF, Gonzales F, Tsai YC and Jones PA. (1994a). Nature, 370, 183-184.
34. Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote R, Dubeau L, Nichols PW, Herman GG, Steven HK, Horn T, Skinner DG and Jones PA. (1994b). Cancer Res., 54, 784-788.
35. Tamimi Y, Bringuier PP, Smit F, van Bokhoven A, Abbas A, Debruyne FM and Schalken JA. (1996). Int. J. Cancer, 68, 183-187.
36. Williamson MP, Elder PA, Shaw ME, Devlin J and Knowles MA. (1995). Hum. Mol. Genet., 4, 1569-1577.
37. Wong DJ, Barrett MT, Stöger R, Emond MJ and Reid BJ. (1997). Cancer Res., 57, 2619-2622.
38. Young RH and Eble JN. (1991). Human Path., 22, 948-965.